Frank is a Managing Partner of GSA and a member of the firm’s Investment Committee. He leads investments across all segments of private equity and offers particular expertise in healthcare venture capital, mid-sized European buyouts and energy-focused private equity funds. He is a member of a number of fund advisory boards. Frank also works closely with clients and has been involved in developing portfolio construction models and forecasting tools for clients. Frank is also a Visiting Executive at Harvard Business School, where he is a guest lecturer in the MBA class Venture Capital and Private Equity.
Prior to joining GSA in 2001, Frank was a co-founder of Biocode Inc., a venture-backed biotech start up where he helped raise $15 million in venture capital over three rounds of financing. During his six-year tenure at Biocode, Frank played a number of executive roles, including 18 months as Managing Director, Asia, based in Singapore, and was a co-inventor on two patents. Previously, Frank spent three years in early-stage venture capital as an Associate at Innotage Management and as an Analyst in the healthcare group of Advent Venture Partners in London.
BA, Interdisciplinary Studies, University of Virginia
MBA, Harvard Business School (Baker Scholar)